CNS Therapeutics Markets, 2016-2024 - Global Strategic Business Report 2017

Anti-Alzheimer's, Anti-Parkinson's, Anti-Epilepsy, Pain Management, Anti-Psychotics, Anti-Depressants & Others

DUBLIN, Jan. 23, 2018 /PRNewswire/ --

The "CNS Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for CNS Therapeutics in US$ Million by the following Product Groups:

• Anti-Alzheimer's
• Anti-Parkinson's
• Anti-Epilepsy
• Pain Management
• Anti-Psychotics
• Anti-Depressants
• Others

The report profiles 162 companies including many key and niche players such as:

• AbbVie Inc.
• Alkermes Plc.
• Allergan, Plc
• Amneal Pharmaceuticals, LLC
• AstraZeneca Plc
• BIAL Group
• Bristol-Myers Squibb
• Eisai Co., Ltd.
• Endo Pharmaceuticals Inc.
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• Fabre-Kramer Pharmaceuticals, Inc.
• GlaxoSmithKline
• H. Lundbeck A/S
• Johnson & Johnson
• Janssen Pharmaceuticals, Inc.
• Merck & Co., Inc.
• Neurocrine Biosciences, Inc.
• Novartis AG
• Otsuka Pharmaceutical Co., Ltd.
• Pfizer, Inc.
• Purdue Pharma L.P.
• Sanofi S.A
• Shire Plc
• Strides Shasun Limited
• Sumitomo Dainippon Pharma Co., Ltd.
• Sunovion Pharmaceuticals, Inc.
• Takeda Pharmaceutical Co., Ltd.
• Teva Pharmaceutical Industries Ltd.
• UCB Group

Key Topics Covered: 

1. INDUSTRY OVERVIEW
CNS Therapeutics Exhibit Robust Opportunities amidst Rising Incidence of CNS Disorders
List of FDA Approved CNS Drugs: 2015 through 2017
Patent Expiries of Major Drugs Exert Downward Pressure on the Global CNS Market
Patent Expiries of Leading CNS Drugs: 2008-2022
Developed Markets to Maintain their Dominance
Developing Market to Drive the Market Momentum

2. MARKET ANALYSIS BY THERAPEUTIC CATEGORIES
Anti-Epilepsy Market
Global Market Overview
Disease Overview
Treatment
Anti-Epileptic Market (AEDs) by Drug Class: List of Drugs under Broad-Spectrum AEDs and Narrow-Spectrum AEDs
Leading Anti-Epileptic Drugs
Leading Anti-Epileptic Drugs and Their Mechanism of Action